| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Cyber Law > Fair Use - When You Should Attribute Your Sources And When You Should Seek Copyright Protection |
|
Top Articles - Fair Use - When You Should Attribute Your Sources And When You Should Seek Copyright Protection
There is some confusion with regard to plagiarism and what constitutes fair use online. Some people are so afraid to violate copyright laws, or have their rights to their own intellectual property violated, that they miss great opportunities to see their work expand According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ed. The blogosphere has its own rules but those rules don’t discount traditional law. Stealing is still stealing, even on the Internet. But allow me to dispel some copyright infringement myths:
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in yright infringement does not entail using another person work if you add content of your own that creates new value lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of another individual’s content If these guidelines seem a big vague, it’s because they are. When it comes to fair use and copyright infringement, there are a lot of gray areas. However, there is still enough black and white to draw some lines in the sand here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . Christopher Alan Jennings of the American Law Division wrote a report for Congress titled “Fair Use on the Internet” and he said that courts weigh four factors with regard to fair use, whether o d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nline or off line:
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc potential market” In the blogosphere, it is considered acceptable to trackback to another individual’s blog or borrow from their blog and add comments of your own. If you engage in this practice, and you should, then do the right thing and link back to y easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi our sources. This is the online equivalent of citing references in your print or off line material. Your link back to the original source constitutes proper attribution. Of course, you could go a step further and identify your source by name, but it isn’t necessary. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically An example of proper attribution would be the above link to the “Fair Use on the Internet” report. By linking back to the original source, you give your readers a chance to check your facts to see if you got them correct but also to see if you are interpreting the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ m correctly. You let the readers be the judge. This will go a long ways with your credibility. Before you use material from another website or blog, ask yourself these questions:
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi /li> This is not elementary and there is more to each of these questions than simply answering them without contemplat ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ion. If the material you want to copy and paste adds new understanding to your topic and provides value for your readership then go ahead and use it, but be sure to give attribution to your source. If your own comments will stand alone without the material you wan dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t to borrow, ask yourself if it is really necessary to borrow. If not, then leave it alone. If there is no way your own material can stand alone without borrowing someone else’s material then maybe you should reconsider your own knowledge of the topic. You want your cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin own material to be able to stand on it’s own. Consider the other person’s work much like graphics on a web page: It is there to enhance, not be the primary focus. Thirdly, if you are not willing to link back to your source then don’t bother using the material. Lin tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen king back is essential as an act of attribution and if you are not willing to do this then leave it alone. So what should you do if you believe your copyrighted material has been stolen? First, right a letter to the webmaster or ezine publisher asking them to remov t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e your material or attribute you as the source. Ask for a link back to your website. If they are not willing to provide that link then ask them to remove your material. If you can’t get the result you want by doing this, go to Alexa or WhoIs and find out who the IS ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust P is. Both websites provide that information and you can contact the ISP to report a violation of law. The ISP will investigate and if they agree with you then they can, and many will, shut the website down. If you go this route, provide the ISP with this informatio y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n:
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de that you are accusing of fair use infringement
Bottom line: Just because your material is used doesn’t mean there is a copyright infringement and even if there is, it might be to your benefit to overlook it. Does the website provide a link back to yo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip u? If so, you are still benefiting from their use of your material. Ask yourself if it is more important to you to control your material in every way or if you want the benefits of links back to your website. You might find yourself saying, “It’s really no big deal. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Don't Use Your Print Ad on Radio 5 Keys to Get Started With PPC Advertising Explore Business Opportunities With Unsecured Business Loans
|